We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGBN icon
1851
Eagle Bancorp
EGBN
$850M
$376K ﹤0.01%
7,718
+1,587
+26% +$80.7K
MATV icon
1852
Mativ Holdings
MATV
$479M
$376K ﹤0.01%
14,991
+7,535
+101% +$232K
SEMG
1853
DELISTED
SEMGROUP CORPORATION
SEMG
$376K ﹤0.01%
27,276
+15,077
+124% +$271K
RGS icon
1854
Regis Corp
RGS
$68.4M
$375K ﹤0.01%
1,106
+37
+3% +$13.2K
ROCK icon
1855
Gibraltar Industries
ROCK
$1.28B
$373K ﹤0.01%
10,481
+2,471
+31% +$90.1K
CEVA icon
1856
CEVA Inc
CEVA
$831M
$371K ﹤0.01%
16,775
-1,660
-9% -$41.5K
VREX icon
1857
Varex Imaging
VREX
$462M
$369K ﹤0.01%
15,587
-12,920
-45% -$328K
LTXB
1858
DELISTED
LegacyTexas Financial Group Inc
LTXB
$369K ﹤0.01%
11,496
+1,966
+21% +$75.1K
CDE icon
1859
Coeur Mining
CDE
$15.1B
$368K ﹤0.01%
82,402
+974
+1% +$4.6K
HY icon
1860
Hyster-Yale Materials Handling
HY
$576M
$367K ﹤0.01%
5,917
+2,125
+56% +$132K
TLRD
1861
DELISTED
Tailored Brands, Inc.
TLRD
$367K ﹤0.01%
26,939
+2,433
+10% +$50.1K
BUSE icon
1862
First Busey Corp
BUSE
$2.55B
$366K ﹤0.01%
+14,913
New +$412K
UIS icon
1863
Unisys
UIS
$252M
$366K ﹤0.01%
31,431
+11,228
+56% +$177K
NAV
1864
DELISTED
Navistar International
NAV
$364K ﹤0.01%
14,026
-7,642
-35% -$239K
INN
1865
Summit Hotel Properties
INN
$766M
$363K ﹤0.01%
37,304
+9,673
+35% +$110K
WOR icon
1866
Worthington Enterprises
WOR
$2.74B
$362K ﹤0.01%
16,864
+2,972
+21% +$74K
GDS icon
1867
GDS Holdings
GDS
$5.93B
$359K ﹤0.01%
15,547
+1,733
+13% +$45.2K
NMRK icon
1868
Newmark Group
NMRK
$2.64B
$358K ﹤0.01%
+44,592
New +$422K
PACB icon
1869
Pacific Biosciences
PACB
$435M
$357K ﹤0.01%
48,262
-460
-0.9% -$2.92K
INOV
1870
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$357K ﹤0.01%
25,185
-3,036
-11% -$34.6K
AORT icon
1871
Artivion
AORT
$1.34B
$355K ﹤0.01%
12,508
+4,190
+50% +$126K
FFIC
1872
DELISTED
Flushing Financial
FFIC
$355K ﹤0.01%
16,511
+6,081
+58% +$136K
BMRC icon
1873
Bank of Marin Bancorp
BMRC
$460M
$354K ﹤0.01%
8,591
+951
+12% +$38.9K
SBGI icon
1874
Sinclair Inc
SBGI
$1.02B
$354K ﹤0.01%
13,444
+2,084
+18% +$60.8K
HIBB
1875
DELISTED
Hibbett, Inc. Common Stock
HIBB
$352K ﹤0.01%
24,583
+536
+2% +$9.11K

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.